Ondansetron

Application Ondansetron hydrochloride dihydrate has been used as a 5-HT 3 antagonist to attenuate rostro ventromedial medulla (RVM)/cholecystokinin (CCK)-induced mechanical hypersensitivity and to block the effects of trichostatin A (TSA) on 5-HT

Application Ondansetron hydrochloride dihydrate has been used as a 5-HT 3 antagonist to attenuate rostro ventromedial medulla (RVM)/cholecystokinin (CCK)-induced mechanical hypersensitivity and to block the effects of trichostatin A (TSA) on 5-HT

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Ondansetron-d 5 is the deuterium labeled Ondansetron. Ondansetron (GR 38032: SN 307) is a serotonin 5-HT3 receptor antagonist used mainly as anantiemetic (to treat nausea and vomiting), often following chemotherapy.In VitroStable heavy isotopes of

A potent, selective inhibitor of SPHK 1 with anti-proliferative activity exhibits non-ATP-competitive inhibition of human recombinant GST-SPHK 1 with an IC50 value of 0.5 &microM, with no inhibition against ERK2, PI3K or PKC&alpha at

InformationWortmannin (KY 12420, SL-2052, BRN 0067676, NSC 627609) is the first describedPI3Kinhibitor withIC50of 3 nM in a cell-free assay, with little selectivity within the PI3K family. Wortmannin blocksautophagosomeformation and potently